Dolphin Medical Services Ltd

Dolphin Medical Services Limited: Trading window closed from Oct 01, 2026 till the end of 48 hours after the announcement/declaration of Un-audited Financial Results (Standalone) for the 2nd Quarter Ended September 30, 2026

Chairman and Promoter Director appointment

• Amarandhar Reddy Kotha appointed Chairman and Promoter Director.
• Designation: Additional Director (Non-Executive Promoter Director).
• Date of appointment: 21 September 2026.
• Relationship: not related to any director.
• Profile: 25 years in IT, Networking, Cyber Security.

Promoter category change for Rajesh Mallour

• Rajesh Kumar Mallour changed from Professional to Promoter Director.
• Reason: Promoter/Promoter Group reclassification.
• DIN: 08125774.
• Effective/status: approved by Board on 21 September 2026.

Committee reconstitution

• Board approved reconstitution of various Committees of the Board.
• Reconstitution per applicable Sections 177, 178 and 135 of the Companies Act, 2013.

Promoter reclassification filings

• Rajesh Kumar Mallour authorised to file intimations for promoter reclassification.
• Filing with Stock Exchanges and other regulators.

Meeting Details

• Date and time: 21 September 2026 at 11:00 A.M.; venue not disclosed.

Key Agenda Items

• Proposed appointment of Amarandhar Reddy Kotha as Chairman and Promoter Director, subject to approvals.
• Change Rajesh Kumar Mallour's category from Professional to Promoter, subject to approvals.
• Reconstitution of Board Committees following proposed changes in board composition.
• Authorize Mallour to file intimations with exchanges/regulators for promoter reclassification after open offer.

Other Notes

• No specific trading window closure period disclosed.

MD & CEO resignation

• G V Mohan Prasad resigns as MD & CEO with immediate effect (12 Sep 2026).

Director resignation: Lakshmi Sudha Madala

• Lakshmi Sudha Madala resigns as Director with immediate effect (12 Sep 2026); no other material reasons confirmed.

Director resignation: Dwarakanath Madala

• Dwarakanath Madala resigns as Director with immediate effect (12 Sep 2026); reason: professional commitments.

AGM extension details

• ROC Hyderabad approved a two-month AGM extension to 30 November 2026.
• FY2025-26 annual general meeting will be held within the extended timeline.
• Original due date was 30 September 2026; extended to 30 November 2026 per order.
• Accounting year ended 31 March 2026; AGM date to be intimated.
• Extension granted under Section 96(1) of Companies Act 2013.
• ROC order dated 31 Aug 2026 granting the extension.

Open offer details

• Open offer to acquire 39,25,988 Dolphin Medical shares at ₹4.80 each (26% stake).
• Acquirers are Amarandhar Reddy Kotha and Mallour Rajesh Kumar; Manager to the Offer is Rarever Financial Advisors.
• Offer opens July 31, 2026; closes August 13, 2026.
• Date of payment of consideration and communication: August 21, 2026.
• Open offer tendered and accepted: 18,000 shares; size ₹86,400.
• Pre-offer, acquirers held 70,90,705 shares (46.96%).
• SPA holdings: 31,63,390 shares (20.95%).
• Post-offer, acquirers hold 31,82,717 shares (21.08%); public 1,10,88,324 shares (73.43%).

Waaree AGM & dividend

• Final dividend ₹1.50 per share for year ended 31 March 2026.
• AGM via VC/OAVM on 23 Sept 2026; record date 11 Sept 2026; e-voting Sept 19-21.

Meeting Details

• Date of board meeting: Friday, August 14, 2026.

Key Agenda Items

• Consider and approve Unaudited Standalone Financial Results for Q1 FY 2026-27 (quarter ended June 30, 2026).

Other Notes

• Trading window for designated persons closed from July 1, 2026 until 48 hours after results publication.

Open Offer details

• Open Offer to acquire up to 39,25,988 equity shares representing 26.00% of voting capital at ₹4.80 per share.
• Acquirers are Amarandhar Reddy Kotha and Mallour Rajesh Kumar; post-offer promoters.

Financials & funding

• Offer size ₹1,88,44,743 assuming full acceptance.
• Escrow ₹1,90,20,000 (over 100% of total consideration) with Axis Bank; funded by acquirers.

Governance & timeline

• Promoter Sellers exit; Acquirers to be promoters after completion.
• SPA enables transfer of management control and board reconstitution on closing.

Timetable & approvals

• Offer opens 31 July 2026; closes 13 August 2026.
• Identified Date 17 July 2026; no minimum acceptance; no competing offer; approvals may trigger withdrawal.

Target company snapshot

• Target: Dolphin Medical Services Limited; diagnostic and healthcare services; listed on BSE.
• FY2026 financials: total income ₹78.69 lakh; PAT ₹4.19 lakh; net worth ₹1,008.13 lakh; EPS ₹0.02.

CFO resignation details

• The resigning CFO is Vaishnavi Sharma.
• Effective date of resignation: not disclosed in the filing.
• Reason: resignation from the roles of Company Secretary cum Compliance Officer and CFO.
• No other material reasons stated.
• Board has accepted the resignation.
• No interim or new CFO appointment disclosed.

Open Offer Overview

• Acquirers: Mr. Amarandhar Reddy Kotha and Mr. Malour Rajesh Kumar.
• Target: Dolphin Medical Services Limited.
• Purpose: acquire 26% voting share capital under takeover regulations.
• Open offer size: up to 39,25,988 shares representing 26% voting capital.
• Price: ₹4.80 per share; total consideration ₹18.84 million.
• Type: open offer to public shareholders.
• Manager: Rarever Financial Advisors Private Limited.

Transaction Background

• Public Announcement dated May 15, 2026.
• Detailed Public Statement published May 22, 2026.
• Draft Letter of Offer dated June 01, 2026.
• Identified date for LO mailing: July 17, 2026.

Timeline and Process

• Eligible participants: public shareholders of the target.
• LOF to be sent to shareholders as on identified date.

Post-Offer Impact

• Post-offer shareholding not disclosed in this excerpt.